Paul Bowness
About
In The Last Decade
Paul Bowness
129 papers receiving 5.9k citations
Peers
Comparison fields: 5 of 127
- Immunology 3.6k
- Rheumatology 2.7k
- Hematology 1.4k
- Molecular Biology 1.2k
- Oncology 443
Countries citing papers authored by Paul Bowness
This map shows the geographic impact of Paul Bowness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bowness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bowness more than expected).
Fields of papers citing papers by Paul Bowness
This network shows the impact of papers produced by Paul Bowness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bowness. The network helps show where Paul Bowness may publish in the future.
Co-authorship network of co-authors of Paul Bowness
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Bowness. A scholar is included among the top collaborators of Paul Bowness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Bowness. Paul Bowness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Pathogenic T-cell clones in axial spondyloarthritis: what is the evidence? | Lara D. Veeken | Frank Penkava, Stephen N. Sansom et al. | 1 |
| 2 | Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis | BMJ Open | Hussein Al‐Mossawi, Paul Bowness et al. | 5 |
| 3 | Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides | Nature | Xinbo Yang, Lee Garner et al. | 85 |
| 4 | A first in disease phase 2A trial of granulocyte monocyte colony stimulating factor neutralisation for axial spondyloarthritis (NAMASTE study) | Clinical and Experimental Rheumatology | Hussein Al‐Mossawi, Chris Worth et al. | 0 |
| 5 | Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism | Proceedings of the National Academy of Sciences | Adam P. Cribbs, Martin Philpott et al. | 73 |
| 6 | CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses | Proceedings of the National Academy of Sciences | Ariane Hammitzsch, C. Tallant et al. | 195 |
| 7 | HLA-B27, ANTIGEN PRESENTATION AND ERAP1 | Clinical and Experimental Rheumatology | Paul Bowness | 1 |
| 8 | WHAT HAVE WE LEARNED ABOUT NON-CLASSICAL FORMS OF HLA-B27 AND ITS ROLE IN THE PATHOGENESIS OF SPONDYLOARTHROPATHIES? | Clinical and Experimental Rheumatology | Kirsty McHugh, Paul Bowness et al. | 1 |
| 9 | CHARACTERIZING TYPE 17 IMMUNE RESPONSES IN ANKYLOSING SPONDYLITIS | Lara D. Veeken | Hussein Al‐Mossawi, Anne J. Ridley et al. | 1 |
| 10 | Increased IL-23 Receptor Expression Is Observed On KIR3DL2+CD4+T Cells In Ankylosing Spondylitis and Correlates With IL-23R Polymorphisms | Immunology | Anne J. Ridley, C. Cohen et al. | 1 |
| 11 | Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis | QUT ePrints (Queensland University of Technology) | Román Fischer, David C. Trudgian et al. | 2 |
| 12 | OVERVIEW OF ANKYLOSING SPONDYLITIS GENETICS AND PATHOGENESIS | Lara D. Veeken | Paul Bowness | 3 |
| 13 | Factors determining the cell surface expression of a novel HLA-B27 epitope | Immunology | Kirsty McHugh, Simon Kollnberger et al. | 1 |
| 14 | Expansion and increased survival of natural killer and CD4 T cells expressing the Killer IG-like Receptor KIR3DL2 in spondyloarthritis. | UCL Discovery (University College London) | Antoni Chan, Simon Kollnberger et al. | 1 |
| 15 | Fully Functional HLA B27-Restricted CD4+ as well as CD8+ T Cell Responses in TCR Transgenic Mice | The Journal of Immunology | Meiyi Sun, Thomas Weissensteiner et al. | 21 |
| 16 | HLA-B27 Heavy Chain Homodimers Are Expressed in HLA-B27 Transgenic Rodent Models of Spondyloarthritis and Are Ligands for Paired Ig-Like Receptors | The Journal of Immunology | Simon Kollnberger, Cécile Hacquard‐Bouder et al. | 103 |
| 17 | MRI CHANGES IN THE CERVICAL SPINE IN PATIENTS WITH ANKYLOSING SPONDYLITIS | Lara D. Veeken | E McNally, P Wordsworth et al. | 5 |
| 18 | Identification of HLA-B27-Restricted Peptides from the Chlamydia trachomatis Proteome with Possible Relevance to HLA-B27-Associated Diseases | The Journal of Immunology | Wolfgang Kuon, Hermann−Georg Holzhütter et al. | 97 |
| 19 | T-CELL RECEPTOR USAGE OF SYNOVIAL LYMPHOCYTES FROM A PATIENT WITH REACTIVE ARTHRITIS | Lara D. Veeken | Paul Bowness, B P Wordsworth et al. | 1 |
| 20 | Operation drawings of Dame Barbara Hepworth. | BMJ | Paul Bowness | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.